Artwork

Content provided by TRC Healthcare. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TRC Healthcare or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Notable New Meds of 2024

31:40
 
Share
 

Manage episode 464409421 series 1070060
Content provided by TRC Healthcare. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TRC Healthcare or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode, TRC Healthcare editors, Sara Klockars, PharmD, BCPS, and Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, discuss notable new meds of 2024.

Listen in as our editors discuss several novel drugs approved in 2024...and highlight some medications now available in a new dosage form. They’ll review efficacy, safety, and considerations for use with these new treatment options.

None of the speakers have anything to disclose.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

Send us a text

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.
Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].

  continue reading

Chapters

1. Notable New Meds of 2024 (00:00:00)

2. Introduction (00:00:02)

3. CE Information (00:01:02)

4. Lebrikizumab (Ebglyss) (00:01:34)

5. Sofpironium (Sofdra) (00:05:35)

6. Ensifentrine (Ohtuvayre) (00:08:21)

7. Xanomeline - Trospium (Cobenfy) (00:12:02)

8. Aprocitentan (Tryvio) (00:14:55)

9. Aripiprazole oral film (Opipza) (00:17:56)

10. Budesonide oral suspension (Eohilia) (00:18:55)

11. Ethinyl estradiol/norethindrone acetate (Femlyv) (00:20:18)

12. Sacubitril/valsartan sprinkle capsule (Entresto) (00:21:47)

13. Clonidine ER oral suspension (Onyda XR) (00:23:12)

14. Minocycline ER capsule (Emrosi) (00:24:26)

15. Carbidopa/levodopa ER capsule (Crexont) (00:25:27)

16. Epinephrine nasal spray (Neffy) (00:26:40)

52 episodes

Artwork

Notable New Meds of 2024

Medication Talk

22 subscribers

published

iconShare
 
Manage episode 464409421 series 1070060
Content provided by TRC Healthcare. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TRC Healthcare or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode, TRC Healthcare editors, Sara Klockars, PharmD, BCPS, and Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, discuss notable new meds of 2024.

Listen in as our editors discuss several novel drugs approved in 2024...and highlight some medications now available in a new dosage form. They’ll review efficacy, safety, and considerations for use with these new treatment options.

None of the speakers have anything to disclose.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

Send us a text

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.
Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].

  continue reading

Chapters

1. Notable New Meds of 2024 (00:00:00)

2. Introduction (00:00:02)

3. CE Information (00:01:02)

4. Lebrikizumab (Ebglyss) (00:01:34)

5. Sofpironium (Sofdra) (00:05:35)

6. Ensifentrine (Ohtuvayre) (00:08:21)

7. Xanomeline - Trospium (Cobenfy) (00:12:02)

8. Aprocitentan (Tryvio) (00:14:55)

9. Aripiprazole oral film (Opipza) (00:17:56)

10. Budesonide oral suspension (Eohilia) (00:18:55)

11. Ethinyl estradiol/norethindrone acetate (Femlyv) (00:20:18)

12. Sacubitril/valsartan sprinkle capsule (Entresto) (00:21:47)

13. Clonidine ER oral suspension (Onyda XR) (00:23:12)

14. Minocycline ER capsule (Emrosi) (00:24:26)

15. Carbidopa/levodopa ER capsule (Crexont) (00:25:27)

16. Epinephrine nasal spray (Neffy) (00:26:40)

52 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play